Thymectomy in mice on neonatal day 3 leads to the development of multiorgan
autoimmune disease due to loss of a CD(+)CD25(+) T cell regulatory populat
ion in their peripheral lymphoid tissues. Here, we report the identificatio
n of a CD4(+) population of regulatory T cells in the circulation of humans
expressing high levels of CD25 that exhibit in vitro characteristics ident
ical with those of the CD4(+)CD25(+) regulatory cells isolated in mice. Wit
h TCR cross-linking, CD4(+)CD25(high) cells did not proliferate but instead
totally inhibited proliferation and cytokine secretion by activated CD4(+)
CD25(-) responder T cells in a contact-dependent manner. The CD4(+)CD25(hig
h) regulatory T cells expressed high levels of CD45RO but not CD45RA, akin
to the expression of CD45RB(low) on murine CD4(+)CD25(+) regulatory cells.
Increasing the strength of signal by providing either costimulation with CD
28 cross-linking or the addition of IL-2 to a maximal anti-CD3 stimulus res
ulted in a modest induction of proliferation and the loss of observable sup
pression in cocultures of CD4(+)CD25(high) regulatory cells and CD4(+)CD25(
-) responder cells. Whereas higher ratios of CD4(+)CD25(high) T cells are r
equired to suppress proliferation if the PD-L1 receptor is blocked, regulat
ory cell function is shown to persist in the absence of the PD-1/PD-L1 or C
TLA-4/B7 pathway. Thus, regulatory CD4 T cells expressing high levels of th
e IL-2 receptor are present in humans, providing the opportunity to determi
ne whether alterations of these populations of T cells are involved in the
induction of human autoimmune disorders.